Previously only available at Dermatologists, Kleresca® creates fluorescent light energy to heal your skin at a cellular level[1]. This non-invasive, scientifically documented technology delivers long-lasting clinics results with little to no downtime[1].
Only at selected Laser Clinics New Zealand locations. Please contact your nearest clinic.
Kleresca® Acne Treatment differs from other acne options due to its unique multi-action mode. Not only does it kill bacteria responsible for acne, but it also reduces inflammation and promotes the build-up of collagen to target acne scarring. The treatment is scientifically tested with 9 out of 10 clients seeing improvements of at least 1IGA[1] or more.
We recommend an initial package of 12 treatments.
Rosacea is a inflammatory skin disorder that is commonly mistaking as ‘redness’. Rosacea often increases in severity over time if left untreated and can include symptoms such as skin irritation, tingling or burning, persistent redness and swelling, and prominent vascular lines.
We recommend a course of 4-6 treatments.
Kleresca® Rejuvenation Treatment is unique in that it is a non-invasive technology which naturally improves your complexion and skin texture, without causing trauma to the skin. Instead of targeting to surface layer of the skin, Kleresca® penetrates at a cellular level to induce collagen production by up to 400%[1], reduce pore size and fine lines and improving overall skin texture and glow.
We recommend a course of 4, or more treatments.
Each treatment session is approximately 9-15 minutes. Clients describe the treatment as pleasant and comfortable. They mention a warm and tingling sensation while they are under the lamp.
Step 1: The skin is cleaned by a Laser Clinics Skin Therapist and the Kleresca®gel is applied.
Step 2: The gel is illuminated for 9 minutes using the multi-LED Kleresca® lamp, together creating fluorescent light energy that stimulates the skin.
Step 3: The gel is removed, and the skin is cleaned and moisturised
Kleresca® skin treatments are gentle and comfortable. The innovative biophotonic platform creates a mode of action unique in the field of dermatology.
The Kleresca® biophotonic platform offers non-invasive treatments for both therapeutic and aesthetic conditions using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms.
Temporary side effects – seen in some clients – are all non-permanent and may include redness, swelling and hyperpigmentation (bronzing of an area of the skin).
Side effects impact patients differently depending on skin type, so we always recommend talking to your therapist before beginning treatment.
Results will vary depending on the treatment you are having as well as your skin condition.
In general, clients treated for acne with Kleresca® Acne Treatment should see noticeable improvements in their skin during the last weeks that the treatment takes place. These improvements should also continue for months after the treatment has stopped. That’s due to the activation of the deeper layers of the skin with the repairing continuing after the treatment has ended.
For Kleresca® Skin rejuvenation, some patients have seen an improvement after just a single treatment, but results will vary from individual to individual. However, thanks to the way Kleresca® Skin Rejuvenation boosts collagen production, improvements will continue even after the full course of four treatments has been completed.
For Kleresca® Rosacea Treatment, some patients have seen an improvement after just a single treatment, but results will vary from individual to individuals. They should see noticeable improvements in their skin during the last weeks of the treatment and these improvements should also continue for months after the treatment has stopped.
Results will last differently depending on the treatment you are having as well as your skin condition.
For Kleresca® Acne Treatment, after finishing the treatment, the already normalised skin continues working and you can expect to see additional improvements to your complexion for months after the treatment has stopped. Persistence of efficacy has been demonstrated for at least 6 months. Experience from current clinics using Kleresca® Acne Treatment show that persistence can last for at least a year.
For Kleresca® Skin Rejuvenation you should experience long-lasting, noticeable improvements to your skin as multiple layers respond to the treatment. The skin repair process has been documented to continue even after the treatment has ended. Results will differ from patient to patient depending on skin quality and if the treatment is administered in combination with other techniques.
For Kleresca® Rosacea Treatment we have seen that the skin repair process has been documented to continue even after the treatment has ended. Patients should experience long-lasting improvements in their skin.
Due to the high safety profile of the treatment, many candidates may benefit from the Kleresca® treatments.
We recommend you to visit your clinic where they will evaluate your skin condition and will determine if Kleresca® is a good treatment for you.
We do not recommend Kleresca® treatments while pregnant or breastfeeding.
Being non-invasive, Kleresca® treatments can be combined with other treatments. We recommend you talk with your clinic to find out what is the best treatment plan for you.
Kleresca® biophotonic platform offers a non-invasive treatment that uses fluorescent light energy. The treatment doesn’t cause destruction to the skin but acts by stimulating your skin’s own repair mechanisms.
Kleresca® biophotonic treatments differ from other light treatments due to its unique mode of action, using fluorescent light energy that stimulates your skin at a cellular level.
The Kleresca® biophotonic system consists of a patented, multi-LED Kleresca® lamp designed with specific, pre-programmed wavelength settings and a specially formulated photoconverter gel.
Chromophores in the gel convert light waves from the lamp into fluorescent light energy that stimulates the skin's own repair mechanisms.
The treatment is performed in the following three steps:
Kleresca® treatments can be done all year around, even in summer. The treatments are well-tolerated and have little to no-downtime.
Ask your clinic about the possible side effects since they might vary depending on your skin type and condition.
Kleresca® is a non-invasive biophotonic treatment, with little to no-downtime. It can be alternated with other treatments, though certain timing intervals apply. Your therapist will recommend a treatment plan suitable for your skin condition.
The use of Kleresca® biophotonic treatments is not recommended in the following situations:
Ask your clinic for more about combination with other treatments.
Clients that have the treatments generally describe it as pleasant and comfortable. They mention a warm and tingling sensation while they are under the lamp.
The treatment is non-invasive and non-destructive, and it doesn’t cause any harm to the skin tissue. The treatment acts by inducing the skin’s own healing mechanisms.
The number of treatments will vary depending on the condition you are treating:
Acne: 12 treatments for the initial course. Maintenance/booster treatments can then be discussed with your therapist if needed.
Rosacea: 4 – 6 treatments depending on your severity, as recommended by your therapist.
Rejuvenate: 4 treatments for the initial course. Maintenance/booster treatments can then be discussed with your therapist if needed.
Kleresca® biophotonic treatments are non-invasive and have limited to no-downtime.
Side effects seen in those treated include, redness, hyperpigmentation (bronzing of an area of the skin) and slight discoloration of hair in some cases where the gel was applied covering facial hair. All side effects were transient and did not require any intervention by the clinic.
Side effects impact patients differently depending on skin type, so we always recommend talking to your clinician before beginning the treatment.
Side effect overview:
Optimal results can be seen at week 12 to 18 from the start of your treatment.
You need to avoid high intensity products for 12 hours prior to your treatment. These include
Remember to avoid excessive sun exposure prior to your treatment also.
Following your treatment it is important you avoid excessive sun exposure and continue to wear your broad spectrum SPF50+ (Skinstitut Age Defence SFP50+). Depending on your
condition treated your therapist will customise your homecare regime to ensure you achieve a better result from your treatments. Please follow the product prescription provided by your therapist.
This will depend on your skin condition being treated and the course of treatments that your therapist recommends. Please consult your local clinic for a thorough skin consultation and prescription.
Kleresca® biophotonic treatments are done using a specific Kleresca® Photoconverter Gel for the indication to be treated together with the Kleresca® Light. The gel is non-invasive, and it is applied on the target skin area, which is then illuminated with the Kleresca® Light, generating fluorescent light energy.
One of the ingredients in the gel are the chromophores, which are the particles responsible for converting the blue light from the lamp into fluorescent light energy.
Kleresca® is a scientifically proven technology with different scientific papers published that explain its high efficacy and efficiency. Side effects, seen in some patients, are all non-permanent and they have not required the intervention rom the treating physician.
Before & After results achieved after a full course of recommended treatments. Individual
results may vary. Always consult your skin therapist for the appropriate treatment plan.
[1] Medical reference from Kleresca® Clinic Trials. Reference list:
1. Nielsen, Schoedt & Bak-Christensen. Clinical Evaluation – Kleresca® Biophotonic Treatments. 2017. Kleresca® Data on File
2. Jalili, A. 2018. Chromophore gel-assisted phototherapy. A novel and promising photobiomodulation therapy for facial inflammatory skin diseases and skin aging. J Ästhet Chir. 2018. Early online 20 February
3. Antoniou, C. et al. 2016. A multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne. Int J Dermatol; 55: 1321 – 1328
4. Nikolis, A. et al. 2018. An extension of a multicentre, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne. Int J Dermatol. 57(1):94-103
5. Nikolis, A. et al. 2016. A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation. Clin Cosmet Investig Dermatol. 13;9:115-25
6. Braun, S.A.& Gerber, P. A photoconverter-gel assisted blue light therapy for the treatment of rosacea. Int. J Dermatol. 2017, 56, 1489-1490.
7. Sannino, M. et al. A novel platform for treating rosacea subtypes 1, 2 and 3 using fluorescent light. Int J Dermatol 2018.